U.S. Army Captain Michael Kelvington, commander of the Battle company, 1-508 Parachute Infantry battalion, 4th Brigade Combat Team, 82nd Airborne Division, bows next to remains of Gulam Dostager, a member of Afghan Local Police who was killed in the blast of an Improvised Explosive Device (IED) during the joint Tor Janda (Black Flag in Pashtu) operation, in Zahri district of Kandahar province, southern Afghanistan May 25, 2012.  REUTERS/Shamil Zhumatov  (AFGHANISTAN - Tags: MILITARY CIVIL UNREST CONFLICT TPX IMAGES OF THE DAY)

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Members of the U.S. Navy Blue Angels fly over the World Trade Center in lower Manhattan as part of the 25th annual Fleet Week celebration in New York, May 23, 2012.  REUTERS/Eduardo Munoz (UNITED STATES - Tags: MILITARY ANNIVERSARY TPX IMAGES OF THE DAY)

Fleet Week

The U.S. Navy takes Manhattan for a week.  Slideshow 

Photo

The SpaceX mission

A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station.  Slideshow 

Republican senator pushes biotech funding

Senator Arlen Specter (R-PA) speaks after a compromise was reached on the stimulus package in Washington, DC, February 11, 2009. REUTERS/Joshua Roberts

Senator Arlen Specter (R-PA) speaks after a compromise was reached on the stimulus package in Washington, DC, February 11, 2009.

Credit: Reuters/Joshua Roberts

Related Topics

WASHINGTON | Mon Apr 27, 2009 10:49am EDT

WASHINGTON (Reuters) - A Senate Republican who could prove a swing vote in the U.S. healthcare debate said on Saturday he wanted a new agency to help struggling biotech companies as part of a future healthcare system.

Senator Arlen Specter said the new agency could be important as Democrats push a health plan that aims to rein in soaring costs and to provide health coverage for an estimated 46 million uninsured Americans.

"I believe that we can live not only longer lives, but healthier lives, by harnessing and applying the genius of our biomedical research community and getting about the task of accelerating cures," Specter said in remarks prepared for a Chicago speech to physicians and researchers.

Specter, who has survived two bouts of cancer, proposed a new agency known as the Cures Acceleration Network that would award grants to cash-strapped biotech companies to help them develop new treatments.

He said these companies are having difficulty tapping into private capital and a number have cut or put on hold important drug development programs that could provide new treatments for cancer, multiple sclerosis, diabetes and other diseases.

"Without adequate funding, these companies will be unable to take these products to the development state, the basic research done by the NIH (National Institutes of Health) will be lost, and many patients will die waiting for drugs and devices to give them a better quality of life," Specter said.

A copy of his speech was made available in Washington.

Specter was able to secure additional funds for NIH as part of the $787 billion economic stimulus package signed into law by President Barack Obama.

Specter's vote for that package got him into trouble with some of his fellow Republicans and he is facing a primary challenge for re-election in Pennsylvania next year from conservative Pat Toomey.

Specter said he would make creation of the new agency and increased funding for NIH a major focus of his re-election bid next year. He also said he would push to include the measure in the sweeping healthcare overhaul that Obama wants.

Democrats control 58 votes in the 100-member Senate and could need the support of at least two Republican votes to overcome any procedural roadblocks.

(Writing by Donna Smith, editing by Vicki Allen)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.